tirzepatide is fda approved FDA-approved for weight management, with clinical trials showing average weight loss of 15–22.5% over 72 weeks. It's a prescription-only therapy, meaning it's not for everyone, and it works by acting Zepbound's New FDA Approval: What

This gives your body time to readjust its metabolic signaling and reduces the severity of rebound symptoms

To minimize regain, its important to maintain physical activity and work with healthcare professionals for ongoing support.

In a clinical trial, an investigator and study team manage the study drug

The British Menopause Society (BMS) has made the following recommendations for this cohort, emphasising that data is notable by its absence: Women using a GLP-1 should ideally use a non-oral form of progestogen alongside their TD oestrogen

Red Flags That Require Urgent Attention Immediate evaluation is needed if the swelling is accompanied by high fever, rapidly progressive enlargement, signs of airway compromise, or severe local infection that could spread